Tyroserleutide (YSL)

Modify Date: 2024-01-02 13:37:25

Tyroserleutide (YSL) Structure
Tyroserleutide (YSL) structure
Common Name Tyroserleutide (YSL)
CAS Number 138168-48-6 Molecular Weight 381.423
Density 1.3±0.1 g/cm3 Boiling Point 763.8±60.0 °C at 760 mmHg
Molecular Formula C18H27N3O6 Melting Point N/A
MSDS N/A Flash Point 415.7±32.9 °C

 Use of Tyroserleutide (YSL)


Tyroserleutide (YSL), isolated from the degradation products of porcine spleen[1], is a small molecular tripeptide which inhibits tumor growth both in vitro and in vivo[2].

 Names

Name Tyroserleutide
Synonym More Synonyms

 Tyroserleutide (YSL) Biological Activity

Description Tyroserleutide (YSL), isolated from the degradation products of porcine spleen[1], is a small molecular tripeptide which inhibits tumor growth both in vitro and in vivo[2].
Related Catalog
Target

Antitumor tripeptide[1][2]

In Vitro Tyroserleutide (YSL) exhibits immuno-modulating effects, such as enhancing concanavalin (ConA) induced proliferation of mouse spleen lymphocytes, phagocytosis of mouse peritoneal macrophages, and the activity of natural killer (NK) cells[1]. Tyroserleutide (YSL), an immunologically therapeutic tripeptide, can promote hepatocarcinoma cell (H22) apoptosis through downregulating Bcl-2 and cyclin D1 expression[2]. Tyroserleutide is an ideal choice for inducing apoptosis of liver tumor cells[2]. Tyroserleutide inhibits tumor growth and does not cause severe toxicities in the major organs. Tyroserleutide can inhibit tumor cell migration[2].
In Vivo Tyroserleutide (10-80 μg/kg; injection (i.p.) one time every day until mice are dead) displays obvious anti-tumor activity. Tyroserleutide significantly prolongs the survival time of the murine H22 implanted mice[1]. Animal Model: Female Kun-Ming mice (18-22 g, 6 week old) with H22 tumor model[1] Dosage: 10, 20, 40, and 80 μg/kg Administration: Injection (i.p.) one time every day until mice were dead. Result: Survival times are 25.53±14.14, 25.82±14.29, 30.47±17.89, 35.06±20.90 days for 10, 20, 40, and 80 μg/kg, respectively.
References

[1]. Wang C, et al. Studies on the large scale synthesis and anti-tumor activity of YSL. Prep Biochem Biotechnol. 2003 Aug;33(3):189-95.

[2]. Liang P, et al. pH-Triggered Conformational Change of Antp-Based Drug Delivery Platform for Tumor Treatment with Combined Photothermal Therapy and Chemotherapy. Adv Healthc Mater. 2019 Aug;8(15):e1900306.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 763.8±60.0 °C at 760 mmHg
Molecular Formula C18H27N3O6
Molecular Weight 381.423
Flash Point 415.7±32.9 °C
Exact Mass 381.189972
LogP 0.89
Vapour Pressure 0.0±2.7 mmHg at 25°C
Index of Refraction 1.577

 Synonyms

L-Tyrosyl-L-seryl-L-leucine
L-Leucine, L-tyrosyl-L-seryl-
Top Suppliers:I want be here

Get all suppliers and price by the below link:

Tyroserleutide (YSL) suppliers

Tyroserleutide (YSL) price